何泓良

何泓良，东南大学青年首席教授，博士生导师，国家级青年人才。主要从事纳米药物设计工作，长期致力于利用纳米技术围绕血管疾病（如动脉粥样硬化、血栓等）构建精准治疗新技术和新方法。近年来主持承担国家自然科学青年基金、南京市留学人员科技创新项目，作为课题骨干参与国家重点研发计划。在Science Advances, ACS Nano, Advanced Science，Biomaterials, Journal of Controlled Release等发表论文40余篇。曾获美国心脏协会博士后研究基金资助，获美国心脏协会Young Investigator Travel Award。担任教育部、科技部及多省科研项目通讯评审专家，同时任Advanced Materials、Advanced Functional Materials、Biomaterials等国际期刊审稿人。任《Nano Research》、《Nano Materials Science》、《Asian Journal of Pharmaceutical Sciences》、《National Science Open》等期刊青年编委。

（欢迎优秀本科生、硕士/博士研究生加入，专业背景包括但不限于生物医学工程，药学、高分子材料、化学等，联系方式：drhe518@seu.edu.cn）！

近5年代表性论文：

1.ShiWang,H He*, Y Mao, Y Zhang*, N Gu*. Advances in Atherosclerosis Theranostics Harnessing Iron Oxide-Based Nanoparticles.Advanced Science 2024 May;11(17):e2308298.

2.H He, Q Han, S Wang, M Long, M Zhang, Y Li, Y Zhang*, N Gu*. Design of a Multifunctional Nanozyme for Resolving the Proinflammatory Plaque Microenvironment and Attenuating Atherosclerosis.ACS Nano 2023,8;17(15):14555-14571.(Suppl. Cover)

3.D Liu,H He, (Equal Contribution) F Kong, Y Cao, F Zang, M Ma*, N Gu*, Y Zhang*, A versatile metal–organic nanoplatform in combination with CXCR4 antagonist and PD-L1 inhibitor for multimodal synergistic cancer therapy and MRI-guided tumor imaging,Nano Today 2022, 47, 101689

4.H He, TA Halseth (Equal Contribution), L Mei, C Shen, L Liu*, A Schwendeman*. Nanodisc delivery of liver X receptor agonist for the treatment of diabetic nephropathy.Journal of Controlled Release 2022, 348, 1016-1027.

5.H He, R Adili (Equal Contribution), L Liu (Equal Contribution), K Hong, M Holinstat, A Schwendeman*. Synthetic high-density lipoproteins loaded with antiplatelet agent for efficiently inhibiting thrombosis in mice.Science Advances 2020 Dec 4;6(49): eabd0130.

6.H He, J Wang, P Yannie, WJ Korzun, H Yang*, S Ghosh*. Nanoparticle-based “Two-pronged” approach to regress atherosclerosis by simultaneous modulation of cholesterol influx and efflux.Biomaterials 2020:120333.